Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Debt Ratio (2021 - 2025)

Historic Debt Ratio for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Q3 2025 value amounting to 0.29.

  • Arcutis Biotherapeutics' Debt Ratio fell 3748.49% to 0.29 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29, marking a year-over-year decrease of 3748.49%. This contributed to the annual value of 0.31 for FY2024, which is 4802.2% down from last year.
  • As of Q3 2025, Arcutis Biotherapeutics' Debt Ratio stood at 0.29, which was down 3748.49% from 0.31 recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Debt Ratio ranged from a high of 0.69 in Q3 2023 and a low of 0.18 during Q4 2021
  • Moreover, its 5-year median value for Debt Ratio was 0.41 (2022), whereas its average is 0.4.
  • As far as peak fluctuations go, Arcutis Biotherapeutics' Debt Ratio soared by 16219.11% in 2023, and later tumbled by 4802.2% in 2024.
  • Arcutis Biotherapeutics' Debt Ratio (Quarter) stood at 0.18 in 2021, then soared by 148.33% to 0.44 in 2022, then skyrocketed by 34.29% to 0.59 in 2023, then tumbled by 48.02% to 0.31 in 2024, then dropped by 4.82% to 0.29 in 2025.
  • Its Debt Ratio was 0.29 in Q3 2025, compared to 0.31 in Q2 2025 and 0.31 in Q1 2025.